New test brings reliable tuberculosis diagnosis to rural Africa

March 1, 2018 by Nathan Collins, Stanford University
Graduate student Mireille Kamariza and chemistry Professor Carolyn Bertozzi developed a fast, inexpensive and reliable test for tuberculosis. Credit: L.A. Cicero

Tuberculosis, a distant memory to most Americans, remains a serious public-health threat in developing countries, in part because the most common test for the disease was developed a century ago and is not the most reliable. Now, a team of basic chemists working in collaboration with doctors and public health researchers in South Africa has developed a new test that makes it easier to diagnose and therefore treat the disease.

The new test, which the researchers describe Feb. 28 in the journal Science Translational Medicine, is designed to work quickly and in places with few of the amenities – even seemingly basic ones like refrigeration – that many of us take for granted, said Carolyn Bertozzi, a professor of chemistry and senior author on the study.

Addressing that challenge took some luck, tuberculosis acumen and passion. "I'm from Burundi – I grew up around infectious disease," said Mireille Kamariza, a graduate student in Bertozzi's lab, who with former Bertozzi graduate student Peyton Shieh is the paper's co-first author. "I am passionate about contributing to that in one way or another."

Four walls, a roof and a door

For those used to modern, high-tech medical care, it can be hard to grasp just what kind of challenge tuberculosis is in places like rural South Africa. Here in the U.S., sophisticated tests yield detailed information, down to the particular strain a patient has. But to work, those tests require conveniences that most Americans take for granted – electricity to run even the most basic equipment, refrigeration to keep test chemicals stable and, perhaps most important, time.

Rural clinics in developing countries – and some urban clinics as well – may not have such luxuries. Some of those clinics are little more than sheds to provide shade and privacy, and they often lack electricity, running water or money to run complicated tests. Patients, meanwhile, often travel long distances to get to a clinic and may or may not return for test results and treatment.

"You're talking about places where complicated technologies that we develop here just don't translate," said Bertozzi, who is also a faculty fellow of Stanford ChEM-H. The best current option, she said, and by far the most common TB diagnostic worldwide, is the Ziehl-Neelsen stain, a test developed in the late 19th century. But while it is inexpensive, it is neither simple nor especially fast or reliable – in fact, the Ziehl-Neelsen test cannot even differentiate between living and dead .

Fast, cheap and good

Bertozzi and her lab have been studying tuberculosis for 20 years. Among their most important discoveries was that of a special sugar molecule, called trehalose, that only living tuberculosis bacteria consume and that other bacteria eschew. Bertozzi's goal back then was mainly to understand how tuberculosis worked, but over time she realized her results might have clinical significance as well.

"More and more I would hear talks from people who were in the field trying to deploy new drug ideas or new diagnostics, and it's been difficult because the environments in which you need to be able to get an accurate diagnosis and then manage the treatment of people with TB are so underresourced," Bertozzi said.

What those people needed, in other words, was a test that was fast, cheap and good. Usually, engineers will tell you, you get to choose just two, but Bertozzi, Kamariza and their colleagues accomplished all three with a solution based on what they'd learned previously about the tuberculosis bacteria's penchant for trehalose. They attached the sugar to a fluorescent dye that, once ingested, glows about 700 times brighter than before: Spot a very bright cell, and live tuberculosis must be present.

The test, called DMN-Tre, takes just a few steps and produces results in under an hour. Because of the test's speed, doctors may be able to test antibiotics against sputum samples to quickly find the right antibiotics for the particular strain a patient carries.

From Stanford to Johannesburg

Still, the real test comes not in the lab but out in the real world with real patients. For that the researchers turned to collaborator Bavesh Kana and his team at the University of Witwatersrand in Johannesburg, South Africa. They conducted tests on 40 tuberculosis patients who had not yet been treated for the disease. DMN-Tre, the researchers found, performed as well as existing tests that took more steps to complete.

Another important test will be seeing whether they can accurately track the decline of tuberculosis bacteria in drug-treated patients, which will take much longer, Kamariza said. Those bacteria, she said, can take three months or more to clear out of a patient's system, so it will be important to assess whether DMN-Tre can help quickly determine drug efficacy during patient treatment in rural areas.

The work so far has already opened up a number of new possibilities, Bertozzi said. Other researchers in South Africa are looking at whether it could help diagnose TB in patients with HIV, for whom standard sputum tests often do not work. DMN-Tre could also help researchers trying to understand how tuberculosis circulates in rooms and buildings. "There is a lot about the life cycle of tuberculosis that people don't understand, and it's hard to study," Bertozzi said. "This tool could be an enabling reagent for a variety of -related research projects."

Explore further: Glowing molecule can reveal live tuberculosis bacteria

Related Stories

Glowing molecule can reveal live tuberculosis bacteria

February 28, 2018
A molecule made in the lab may change the way tuberculosis is diagnosed in the field.

Simple new test could improve diagnosis of tuberculosis in developing nations

August 22, 2016
In developing nations, the current test to diagnose tuberculosis (TB) is error-prone, complicated and time-consuming. Furthermore, patients in these resource-limited areas can't easily travel back to a clinic at a later date ...

Urine test developed to test for tuberculosis

December 14, 2017
(Medical Xpress)—An international team of researchers has developed a urine test that can be used to detect tuberculosis (TB) in human patients. In their paper published in Science Translational Medicine, the group describes ...

Scientists develop a quick, cheap and portable test for diagnosing tuberculosis

May 17, 2017
A microchip-based test developed by A*STAR researchers can diagnose tuberculosis in 15 minutes. The test meets the speed, cost, accessibility and disposal standards recommended by the World Health Organization for detecting ...

Recommended for you

Flu season forecasts could be more accurate with access to health care companies' data

September 19, 2018
In an era when for-profit companies collect a wealth of data about us, new research from The University of Texas at Austin shows that data collected by health care companies could—if made available to researchers and public ...

Researchers discover influenza virus doesn't replicate equally in all cells

September 19, 2018
The seasonal flu is caused by different subtypes of Influenza A virus and typically leads to the death of half a million people each year. In order to better understand this virus and how it spreads, University of Minnesota ...

Drugs that stop mosquitoes catching malaria could help eradicate the disease

September 18, 2018
Researchers have identified compounds that could prevent malaria parasites from being able to infect mosquitoes, halting the spread of disease.

Vaccine opt-outs dropped slightly when California added more hurdles

September 18, 2018
In response to spiking rates of parents opting their children out of vaccinations that are required to enroll in school—and just before a huge outbreak of measles at Disneyland in 2014—California passed AB-2109. The law ...

New evidence of a preventative therapy for gout

September 17, 2018
Among patients with cardiovascular disease, it's a common complaint: a sudden, piercing pain, stiffness or tenderness in a joint that lasts for days at a time with all signs pointing to a gout attack. Gout and cardiovascular ...

"Atypical" virus discovered to be driver of certain kidney diseases

September 14, 2018
An international research team led by Wolfgang Weninger has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy). This "atypical" virus, which the scientists ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.